Mediphar Labs. has launched NAXIDERM® gel in 2019 in the Lebanese market.

NAXIDERM® gel is indicated for the treatment of mild or moderate inflammatory forms of acne vulgaris. It is highly effective and safe monotherapy for acne and bacterial skin infections, prevents the onset of scar formation and the bacterial resistance to nadifloxacin compared to others is extremely low.

We are proud to be introducing this medicament into the market, providing patients with a new and effective treatment option for acne.

NAXIDERM® is available in the below dosage

 • nadifloxacin 1%, tube of 30 g